HENNION & WALSH ASSET MANAGEMENT, INC. – NGM Biopharmaceuticals, Inc. Transaction History
HENNION & WALSH ASSET MANAGEMENT, INC. portfolio value:
$2.29M
portfolio value
HENNION & WALSH ASSET MANAGEMENT, INC. quarter portfolio value change:
+2.03%
quarter
NGM Biopharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.45% | 5.84K shares | 120K | $13.08 | 175.18K |
| Q2 2022 | share | Decrease | -31.25% | -76.98K shares | -1.58M | $12.82 | 169.33K |
| Q1 2022 | share | Decrease | -4.06% | -10.43K shares | -791K | $15.25 | 246.32K |
| Q4 2021 | share | Decrease | -7.30% | -20.23K shares | -1.27M | $17.56 | 256.75K |
| Q3 2021 | share | Decrease | -3.31% | -9.46K shares | 173K | $21.02 | 276.99K |
| Q2 2021 | share | Increase | +10.24% | 26.61K shares | -1.90M | $19.72 | 286.45K |
| Q1 2021 | share | Increase | 0.00% | 259.84K shares | 7.55M | $29.07 | 259.84K |